OPSUMIT Trademark

Trademark Overview

On Thursday, September 13, 2012, a trademark application was filed for OPSUMIT with the United States Patent and Trademark Office. The USPTO has given the OPSUMIT trademark a serial number of 85727907. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Monday, October 4, 2021. This trademark is owned by Actelion Pharmaceuticals Ltd. The OPSUMIT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; Pharmaceutical preparations for the treatment of inflammatory diseases
opsumit

General Information

Serial Number85727907
Word MarkOPSUMIT
Filing DateThursday, September 13, 2012
Status710 - CANCELLED - SECTION 8
Status DateMonday, October 4, 2021
Registration Number4589297
Registration DateTuesday, August 19, 2014
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 25, 2012

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the word "OPSUMIT" and an arrow design above the wording.
Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; Pharmaceutical preparations for the treatment of inflammatory diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, October 4, 2021
Primary Code005
First Use Anywhere DateMonday, November 4, 2013
First Use In Commerce DateMonday, November 4, 2013

Trademark Owner History

Party NameActelion Pharmaceuticals Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAllschwil CH-4123
CH
Party NameActelion Pharmaceuticals Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAllschwil CH-4123
CH
Party NameActelion Pharmaceuticals Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAllschwil CH-4123
CH

Trademark Events

Event DateEvent Description
Tuesday, October 5, 2021NOTICE OF CANCELLATION SEC. 8 EMAILED
Monday, October 4, 2021CANCELLED SEC. 8 (6-YR)
Thursday, October 8, 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Tuesday, October 6, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 18, 2020TEAS SECTION 8 & 15 RECEIVED
Monday, August 19, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 6, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 6, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 19, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, July 15, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 14, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 8, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 8, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 27, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 4, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 4, 2014NON-FINAL ACTION E-MAILED
Tuesday, March 4, 2014SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 4, 2014STATEMENT OF USE PROCESSING COMPLETE
Friday, February 14, 2014USE AMENDMENT FILED
Tuesday, March 4, 2014EXTENSION 2 GRANTED
Friday, February 14, 2014EXTENSION 2 FILED
Sunday, March 2, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 14, 2014TEAS EXTENSION RECEIVED
Friday, February 14, 2014TEAS STATEMENT OF USE RECEIVED
Friday, July 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2013EXTENSION 1 GRANTED
Wednesday, July 10, 2013EXTENSION 1 FILED
Wednesday, July 10, 2013TEAS EXTENSION RECEIVED
Thursday, May 30, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 19, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 25, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 25, 2012PUBLISHED FOR OPPOSITION
Wednesday, December 5, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 21, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 20, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 20, 2012PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, November 13, 2012ASSIGNED TO LIE
Friday, November 2, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 22, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 22, 2012NON-FINAL ACTION E-MAILED
Monday, October 22, 2012NON-FINAL ACTION WRITTEN
Wednesday, October 17, 2012ASSIGNED TO EXAMINER
Wednesday, September 19, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, September 18, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 17, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

opsumit pharmaceutical diseases treatment preparations inflammatory cardiovascular pulmonary